Carina Storrs, PhD

Carina Storrs holds a PhD from Columbia University, where she studied human papillomavirus; she also holds Master's in journalism from New York University.

All articles by Carina Storrs, PhD

News

How to Support Cancer Patients and Caregivers in the Workforce

Carina Storrs, PhD

July 25, 2022

Experts outline ways in which health care providers and employers can support cancer patients and caregivers in the workforce.

Urology

Cancer Patients May Have Double the Risk of Breakthrough Infection After COVID-19 Vaccination

Carina Storrs, PhD

December 16, 2021

A meta-analysis suggests that patients with cancer may be twice as likely as non-cancer patients to have a breakthrough infection after being fully vaccinated.

Practice Management

Age and Race May Determine Whether Cancer Patients Access Their Electronic Health Records

Carina Storrs, PhD

June 4, 2021

Black cancer patients were 44% less likely than White patients to enroll in a portal that provides access to electronic health records.

New study data offer insight on the mechanisms of angiotensin converting enzyme 2 (ACE2) in clear cell renal cell carcinoma (ccRCC).

Genitourinary Cancers Symposium

ACE2 Pathway Stimulation Enhances VEGF Inhibition in ccRCC, May Help Overcome VEGF Resistance

Carina Storrs, PhD

March 4, 2021

New study data offer insight on the mechanisms of angiotensin converting enzyme 2 (ACE2) in clear cell renal cell carcinoma (ccRCC).

Kidney Cancer

Surgery May Not Be Most Appropriate Frontline Tx in mRCC

Carina Storrs, PhD

January 22, 2019

Evidence suggests that starting on systemic drug therapy immediately may be the best approach for some patients with metastatic RCC.

Next post in Kidney Cancer

Carina Storrs, PhD

All articles by Carina Storrs, PhD

How to Support Cancer Patients and Caregivers in the Workforce

Cancer Patients May Have Double the Risk of Breakthrough Infection After COVID-19 Vaccination

Age and Race May Determine Whether Cancer Patients Access Their Electronic Health Records

ACE2 Pathway Stimulation Enhances VEGF Inhibition in ccRCC, May Help Overcome VEGF Resistance

Surgery May Not Be Most Appropriate Frontline Tx in mRCC

Kidney Stones Up Kidney Cancer Risk